EG-70 (phase 1) Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Phase 1

Filter by location:

Birmingham, Alabama1 trial

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

The University of Alabama at Birmingham Clinical Research Unit (CRU)

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.